GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Interest Coverage

Incanthera (AQSE:INC) Interest Coverage : No Debt (1) (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Incanthera's Operating Income for the six months ended in Sep. 2024 was £-0.70 Mil. Incanthera's Interest Expense for the six months ended in Sep. 2024 was £0.00 Mil. Incanthera has no debt. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Incanthera PLC has no debt.

(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Incanthera's Interest Coverage or its related term are showing as below:

AQSE:INC' s Interest Coverage Range Over the Past 10 Years
Min: No Debt   Med: No Debt   Max: No Debt
Current: No Debt


AQSE:INC's Interest Coverage is ranked better than
98.67% of 377 companies
in the Biotechnology industry
Industry Median: 119.89 vs AQSE:INC: No Debt

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Incanthera Interest Coverage Historical Data

The historical data trend for Incanthera's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Incanthera Interest Coverage Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Interest Coverage
No Debt No Debt No Debt N/A No Debt

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only No Debt N/A N/A No Debt No Debt

Competitive Comparison of Incanthera's Interest Coverage

For the Biotechnology subindustry, Incanthera's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Incanthera's Interest Coverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Incanthera's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Incanthera's Interest Coverage falls into.


;
;

Incanthera Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Incanthera's Interest Coverage for the fiscal year that ended in Mar. 2024 is calculated as

Here, for the fiscal year that ended in Mar. 2024, Incanthera's Interest Expense was £0.00 Mil. Its Operating Income was £-1.38 Mil. And its Long-Term Debt & Capital Lease Obligation was £0.00 Mil.

Incanthera had no debt (1).

Incanthera's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Here, for the six months ended in Sep. 2024, Incanthera's Interest Expense was £0.00 Mil. Its Operating Income was £-0.70 Mil. And its Long-Term Debt & Capital Lease Obligation was £0.00 Mil.

Incanthera had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Incanthera  (AQSE:INC) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Incanthera Interest Coverage Related Terms

Thank you for viewing the detailed overview of Incanthera's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Incanthera Business Description

Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera Headlines